UChicago researchers have developed a new blood test that uses RNA modifications to detect early-stage colorectal cancer with 95% accuracy ...

We were able to detect 100% of recurrences by ctDNA ahead of clinical recurrence, which included all lung metastases as well as other distant metastases,” said Emma Titmuss.

Cancer cells mount an instant, energy‑rich response to being physically squeezed, according to a study published in the journal Nature Communications.

While the liquid biopsy technology continues to evolve for lung cancer management, researchers are working toward further ...